SALVAGE CRYOSURGERY
Authors:
A. E. Katz
Authors place of work:
Urology Columbia Medical Center
Published in the journal:
Urol List 2009; 7(3): 30-35
Summary
The author in his article presents an overview and scientific background for cryotherapy and its possible use in prostate cancer treatment. As major indication salvage cryotherapy can be considered in patients without metastatic disease who failed radiotherapy. Proper selection of patient plays a key role in achieving of optimal treatment results. The author discusses the most optimal indication criteria because we still do not have any accurately defined criteria today. Technical advancement of that technology enabled to reach better results and to decrease the incidence of complications. Currently published complication rates presented in this article can be considered very low (with the exception of erectile dysfunction). Cryotherapy can be considered as very effective modality for organ confined prostate cancer treatment after radiation failure.
Key words:
prostate cancer, radiotherapy failure, salvage cryotherapy
Zdroje
1. Ragde H, Elgamal A-A, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided Iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998; 83 (5): 989–1001.
2. Stock RG, Stone NN, DeWyngaert JK, et al. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer 1996; 77 (11): 2386–2392.
3. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome of prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41 (3): 491–500.
4. Dinges S, Deger S, Koswig S, et al. High-dose rate interstitial with external beam irradiation for localized prostate cancer-results of a prospective trial. Radiother Oncol 1998; 48 (2): 197–202.
5. Crook JM, Bunting PS. Percent free prostate-specific antigen after radiotherapy for prostate cancer. Urology 1998; 52 (1): 100–105.
6. Babaian RJ, Kojima M, Saitoh M, et al. Detection of residual prostate cancer after external radiotherapy. Cancer 1995; 75 (8): 2153–2158.
7. Laverdiere J, Gomez JL, Cusan L, et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 37: 247–252.
8. Ljung G, Norberg M, Hansson H, et al. Transrectal ultrasonically-guided core biopsies in the assessment of local cure of Prostatic cancer after radical external beam radiotherapy. Acta Oncologica 1995; 34 (7): 945–952.
9. Roach M 3rd, Hanks G, Thames H Jr et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65 (4): 965–74.
10. Crook J, Malone S, Perry G et al. Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 2000; 48 (2): 355–367.
11. Baust JG, Gage AA. The Molecular Basis of Cryosurgery. BJU Intl. 2005; 95 (9): 1187–1191.
12. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002; 60: 40–49.
13. Baust JG, Gage AA, Klossner D, Clarke D, Miller R, Cohen J, Katz A, Polascik T, Clarke H, Baust JM. Critical Issues in the Successful Application of Cryosurgical Ablation of the Prostate. Technol Cancer Res Treat 2007; 6: 97–109.
14. Long JP, Bahn D, Lee F, Shinohara K et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001; 57: 518–523.
15. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 2005; 103 (8): 1625–1630.
16. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60: 3–11.
17. Stock RG, Stone NN, Cesaretti JA. Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications. Int J Radiat Oncol Biol Phys 2003; 56 (2): 448–453.
18. Rosser CJ, Kuban DA, Levy LB et al. Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. J Urol 2002; 168 (5): 2001–2005.
19. Spiess PE et al. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 2006;107 (2): 275–80.
20. Sartor CI, Strawderman MH, Lin XH et al. Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy. Int J Radiat Oncol Biol Phys 1997; 38 (5): 941–947.
21. Crook JM, Bahadur YA, Robertson SJ et al. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer 1997; 79 (1): 81–89.
22. Eichler K, Hempel S, Wilby J et al. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006; 175 (5): 1605–1612
23. Gheiler EL, Tefilli MV, Tiguert R et al. Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology 1998; 51 (5): 789–795.
24. Chin JL, Pautler SE, Mouraviev V et al. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001; 165: 1937–1941.
25. Pound CR, Partin AW, Epstein JI et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 1997; 24 (2): 395–406.
26. Pisters LL, von Eschenbach AC, Scott SM et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997; 157 (3): 921–925.
27. Bales GT, Williams MJ, Sinner M et al. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology1995; 46 (5): 676–680.
28. Cespedes RD, von Eschenbach AC, McGuire EJ. Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urology 1997; 157 (1): 237–240.
29. Bahn DK, Lee F, Silverman P et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2003; 2 (2): 111–114.
30. de la Taille A, Hayek O, Benson MC et al. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology 2000; 55 (1): 79–84.
31. Ghafar MA, Johnson CW, de la Taille A et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001; 166 (4): 1333–1337.
32. Chin JL, Pautler SE, Mouraviev V et al. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001; 165: 1937–1941.
33. Cresswell J, Asterling S, Chaudhary M et al. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int 2006; 97 (5): 969– 974.
34. Han KR, Belldegrun AS: Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004; 93 (1): 14–18.
35. Donnelly BJ, Saliken JC, Ernst DS et al. Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer and Prostatic Diseases. 2005; 8 (3): 235–242.
36. Robinson JW, Donnelly BJ, Coupland K et al. Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy. Urologic Oncology 2006; 24 (6): 472– 486.
37. Anastasiadis AG, Sachdev R, Salomon L, Katz AE. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol 2003; 129 (12): 676–682.
Štítky
Paediatric urologist UrologyČlánok vyšiel v časopise
Urological Journal
2009 Číslo 3
Najčítanejšie v tomto čísle
- THE HOLMIUM LASER IN THE TREATMENT OF BENIGN PROSTATIC ENLARGEMENT
- GREENLIGHT PVP. MAYO CLINIC APPROACH, SURGICAL TECHNIQUE, AND OUTCOMES
- Therapeutic Options for Advanced Prostate Cancer. Management of locally advanced and androgen dependent prostate cancer
- Role of radical prostatectomy in the treatment of prostate cancer confined to prostate gland. Reality and myth, truth and fiction about robotic assisted radical prostatectomy